Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer

Introduction: Loco regional persistence or recurrence of differentiated thyroid cancer (DTC) is frequent despite initial thyroidectomy and radioactive iodine therapy (RAI). The aim of this study was to analyze the impact of a complementary adjuvant RAI (Ad-RAI) on disease recurrence following re-ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouvet, Clément, Barres, Bertrand, Kwiatkowski, Fabrice, Batisse-Lignier, Marie, Chafai El Alaoui, Meryem, Kauffmann, Philippe, Cachin, Florent, Tauveron, Igor, Kelly, Antony, Maqdasy, Salwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776597/
https://www.ncbi.nlm.nih.gov/pubmed/31611847
http://dx.doi.org/10.3389/fendo.2019.00671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776597/
https://www.ncbi.nlm.nih.gov/pubmed/31611847
http://dx.doi.org/10.3389/fendo.2019.00671

Ejemplares similares